Semaglutide
GLP-1 receptor agonist for metabolic health optimization, supporting healthy weight management and glucose metabolism.
Latest Batch Verified
Lot BSL032026 · Tested Mar 8, 2026HPLC purity, identity (MS), endotoxin, heavy metals — all specs passed. Spec table + per-test methodology available on the public COA page.
View Full COA Test ReportConsulta al por Mayor
10+ viales · OEM / Marca Privada · Envío en Cadena de Frío
Cotización de Fábrica por WhatsAppSemaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used in metabolic health research and clinician-supervised care. This product page is an educational resource for qualified professional inquiries and summarizes available 0.25mg, 0.5mg, and 1mg formats.
Available Dosages
0.25mg
Starting dose for titration protocol
Key Benefits
- Supports healthy weight management
- Promotes glucose metabolism optimization
- GLP-1 receptor agonist mechanism
- Graduated dosing: 0.25mg, 0.5mg, 1mg
- Evidence-based therapeutic approach
- Supports metabolic health goals
Scientific Background
Semaglutide mimics the action of GLP-1, a hormone that regulates appetite and food intake. Clinical studies have demonstrated significant efficacy in supporting weight management and metabolic health when combined with lifestyle modifications.
Educational Display Only
This product information is for educational purposes. Always consult licensed healthcare providers for personalized medical advice.
Frequently Asked Questions
Related Educational Guides
Explore Related Topics
Browse by Category
Related Topics
Related Products
NAD+
Cellular health supplement supporting NAD+ levels, a crucial coenzyme involved in energy metabolism and cellular repair processes.
Available: 100mg, 200mg, 500mg
Tirzepatide
Dual GIP/GLP-1 receptor agonist representing the next generation of metabolic health therapeutics.
Available: 2.5mg, 5mg, 7.5mg, 15mg, 20mg, 30mg
Tirzepatide 2.5mg
Tirzepatide 2.5mg starting-dose research vial — entry-level dual GIP/GLP-1 receptor agonist for pilot studies and dose-titration protocols.